TY - JOUR
T1 - Dysregulation of Myosin Complex and Striated Muscle Contraction Pathway in the Brains of ALS-SOD1 Model Mice
AU - Xu, Benhong
AU - Zheng, Chengyou
AU - Chen, Xiao
AU - Zhang, Zaijun
AU - Liu, Jianjun
AU - Spencer, Peter
AU - Yang, Xifei
N1 - Funding Information:
This work was supported by the National Natural Science Foundation of China (Grants 81801089, 81673134, 81401570), Guangdong Natural Science Foundation (Grant2018A030313242), China Postdoctoral Science Foundation funded project (Grants BX201700162, 2018M630992), Sanm-ing Project of Medicine in Shenzhen (Grant SZSM201611090) and Basic Research Program (Grant no. JCYJ20160428142632408).
Publisher Copyright:
© 2019 American Chemical Society.
PY - 2019/5/15
Y1 - 2019/5/15
N2 - Amyotrophic lateral sclerosis (ALS) is a progressive and fatal disease characterized by cortical and spinal motor neuron degeneration, some inherited cases of which are caused by mutations in the gene coding for copper-zinc superoxide dismutase-1 (SOD1). The SOD1G93A mutant model mouse, which expresses large amounts of mutant SOD1, develops adult-onset neurodegeneration of spinal motor neurons and progressive motor deficits leading to paralysis. We used the Tandem Mass Tag technique to investigate the proteome profile of hippocampus, cerebral cortex, and medulla oblongata of the SOD1G93A mutant model mice as compared with that of wild-type (WT) mice. Fifteen proteins were significantly increased or decreased (i.e., changed) in all three tissues. Gene ontology analysis revealed that the changed proteins were mainly enriched in negative regulation of reactive oxygen species, myosin complex and copper ion binding. In the Striated Muscle Contraction Pathway, most of the identified proteins were decreased in the SOD1G93A mice compared with the WT mice. Myosin-1 (MYH1), fructose-2,6-bisphosphatase TIGAR (TIGAR), and sarcoplasmic/endoplasmic reticulum calcium ATPase 1 (ATP2A1) were significantly reduced in mutant vs WT mice, as confirmed by Western blot analysis. Since myosins and tropomyosins are specific for synapse function and drive actin dynamics in the maturation of dendritic spines, changes in these proteins may contribute to perturbations of brain neuronal circuitry in addition to spinal motor neuron disease.
AB - Amyotrophic lateral sclerosis (ALS) is a progressive and fatal disease characterized by cortical and spinal motor neuron degeneration, some inherited cases of which are caused by mutations in the gene coding for copper-zinc superoxide dismutase-1 (SOD1). The SOD1G93A mutant model mouse, which expresses large amounts of mutant SOD1, develops adult-onset neurodegeneration of spinal motor neurons and progressive motor deficits leading to paralysis. We used the Tandem Mass Tag technique to investigate the proteome profile of hippocampus, cerebral cortex, and medulla oblongata of the SOD1G93A mutant model mice as compared with that of wild-type (WT) mice. Fifteen proteins were significantly increased or decreased (i.e., changed) in all three tissues. Gene ontology analysis revealed that the changed proteins were mainly enriched in negative regulation of reactive oxygen species, myosin complex and copper ion binding. In the Striated Muscle Contraction Pathway, most of the identified proteins were decreased in the SOD1G93A mice compared with the WT mice. Myosin-1 (MYH1), fructose-2,6-bisphosphatase TIGAR (TIGAR), and sarcoplasmic/endoplasmic reticulum calcium ATPase 1 (ATP2A1) were significantly reduced in mutant vs WT mice, as confirmed by Western blot analysis. Since myosins and tropomyosins are specific for synapse function and drive actin dynamics in the maturation of dendritic spines, changes in these proteins may contribute to perturbations of brain neuronal circuitry in addition to spinal motor neuron disease.
KW - SOD1
KW - amyotrophic lateral sclerosis
KW - copper-zinc superoxide dismutase-1
KW - muscle contraction
KW - proteomics
UR - http://www.scopus.com/inward/record.url?scp=85065921591&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065921591&partnerID=8YFLogxK
U2 - 10.1021/acschemneuro.8b00704
DO - 10.1021/acschemneuro.8b00704
M3 - Article
C2 - 30889949
AN - SCOPUS:85065921591
SN - 1948-7193
VL - 10
SP - 2408
EP - 2417
JO - ACS Chemical Neuroscience
JF - ACS Chemical Neuroscience
IS - 5
ER -